POLYMEDCO LLC

Polymedco LLC specializes in the manufacturing and supply of fecal immunochemical test (FIT) kits and related diagnostic mailers for colorectal cancer screening programs, with a primary focus on analytical laboratory instrumentation used in point-of-care and decentralized testing environments. The company’s technical expertise lies in the design, production, and logistics support of in-vitro diagnostic devices that enable non-invasive, high-sensitivity detection of occult blood in stool samples. Their solutions are engineered for ease of use by veterans and clinical staff alike, integrating sample collection, preservation, and return packaging into a single, compliant system. Key differentiators include consistent delivery of FDA-cleared diagnostic kits, seamless integration with VA screening protocols, and a proven ability to scale production for nationwide public health initiatives. The Department of Veterans Affairs is Polymedco’s predominant partner, consistently awarding contracts for FIT kit procurement and distribution to support colorectal cancer prevention efforts across VA medical centers. These engagements reflect a deep alignment with VA’s population health strategy, particularly in rural and underserved veteran communities where access to colonoscopy is limited. The company’s relationship with the VA is characterized by repeat, high-frequency ordering cycles, indicating sustained operational reliability and adherence to clinical guidelines. Polymedco’s industry focus centers on analytical laboratory instrument manufacturing and in-vitro diagnostic substance production, positioning them as a niche supplier within the clinical diagnostics supply chain. Their work supports preventive screening infrastructure, distinguishing them from broad-spectrum medical device manufacturers. The company operates from Cortlandt Manor, New York, as a small business with no federal certifications listed, and maintains a focused market presence centered on federal healthcare delivery systems, particularly those requiring scalable, low-cost diagnostic solutions for large-scale screening programs.